Renewed optimism and significant opportunities exist for biopharma companies. The most successful companies will have robust scientific, commercial, and operational capabilities to thrive in an increasingly value-based health care environment. Whether in specialty care, primary care, biotech, pharma, generics, or the consumer or over-the-counter segment, this is an exciting—and unprecedented—time for a global industry poised to deliver outcomes that create proven value for patients.
What is the right amount to spend on biopharma R&D? Winning companies are taking a flexible approach.Discover more insights
Externally sourced innovation and growth are critical to success. BCG's exclusive Biopharma Partnering Survey and Benchmarking analysis examines licensing and business development activity in the global biopharmaceutical industry.Explore our solutions
See how BCG helped a biopharma company transform the organization through a refined R&D process, rapid scaling in manufacturing, and an improved go-to-market strategy.Read about our impact